Showing 281 - 300 results of 570 for search '"melanoma"', query time: 0.10s Refine Results
  1. 281
  2. 282
  3. 283

    Characterising melanoma diagnostic pathways for patients in routine practice using administrative health data in Ontario, Canada: a population-based study by Frances C Wright, Timothy P Hanna, Patti A Groome, Nicole J Look Hong, Meaghan E Mavor, Yuka Asai, Hugh Langley

    Published 2025-01-01
    “…Objective To characterise diagnostic pathways for patients with melanoma in routine practice and compare patient, disease and diagnostic interval (DI) characteristics across pathways.Design Descriptive cross-sectional study using administrative health data.Setting Population-based study in Ontario, Canada.Participants Patients with melanoma diagnosed from 2007 to 2019.Main outcome measures We used latent class cluster analysis to create clusters of patients with similar diagnostic experiences to characterise diagnostic pathways in routine practice. …”
    Get full text
    Article
  4. 284
  5. 285

    Melanoma Disparities among US Hispanics: Use of the Social Ecological Model to Contextualize Reasons for Inequitable Outcomes and Frame a Research Agenda by Valerie M. Harvey, Charlene W. Oldfield, Jarvis T. Chen, Karl Eschbach

    Published 2016-01-01
    “…Cutaneous melanoma is a significant public health concern, accounting for thousands of deaths annually in the US. …”
    Get full text
    Article
  6. 286

    H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma by Danielle R. Martinez, Hunter W. Richards, Qiushi Lin, Carlos A. Torres-Cabala, Victor G. Prieto, Jonathan L. Curry, Estela E. Medrano

    Published 2012-01-01
    “…Finally, our analysis of H3K79me3T80ph using a tissue microarray indicates that H3K79me3T80ph marks a subset of primary cutaneous melanomas with metastatic potential indicating that H3K79me3T80ph may identify a subset of invasive melanomas with a more aggressive clinical behaviour.…”
    Get full text
    Article
  7. 287

    Pigmented Nodular Basal Cell Carcinomas in Differential Diagnosis with Nodular Melanomas: Confocal Microscopy as a Reliable Tool for In Vivo Histologic Diagnosis by Alice Casari, Giovanni Pellacani, Stefania Seidenari, Anna Maria Cesinaro, Francesca Beretti, Patrizia Pepe, Caterina Longo

    Published 2011-01-01
    “…Nodular basal cell carcinoma, especially when pigmented, can be in differential diagnosis with nodular melanomas, clinically and dermoscopically. Reflectance confocal microscopy is a relatively new imaging technique that permits to evaluate in vivo skin tumors with a nearly histological resolution. …”
    Get full text
    Article
  8. 288

    Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy by Fermín E. González, Alexey Chernobrovkin, Cristián Pereda, Tamara García-Salum, Andrés Tittarelli, Mercedes N. López, Flavio Salazar-Onfray, Roman A. Zubarev

    Published 2018-01-01
    “…During the last decade, we demonstrated that vaccination of advanced melanoma patients with autologous tumor antigen presenting cells (TAPCells) loaded with an allogeneic heat shock- (HS-) conditioned melanoma cell-derived lysate (called TRIMEL) is able to induce an antitumor immune response associated with a prolonged patient survival. …”
    Get full text
    Article
  9. 289

    Prognostic Factors and Nomograms for Overall and Cancer-Specific Survival of Patients with Uveal Melanoma without Metastases: A SEER Analysis of 4119 Cases by Xin Liu, Chang Liu, Yue Shang, Lin Yang, Fengling Tan, Yong Lv

    Published 2022-01-01
    “…To determine prognostic factors for patients with uveal melanoma without metastases and to construct nomograms to predict their 3- and 5-year overall survival (OS) and cancer-specific survival (CSS). …”
    Get full text
    Article
  10. 290
  11. 291

    Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights by Juan Li, Xuan Wang, Li Zhou, Jun Guo, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoting Wei, Xinan Sheng, Siming Li, Zhihong Chi, Lili Mao, Bin Lian, Xieqiao Yan, Yan Kong, Caili Li, Xiangyong Gu, Binlei Liu, Hui Tian, Han Hu

    Published 2025-02-01
    “…A phase Ia/Ib clinical trial in China was conducted in patients with unresected stage III–IV melanoma, the majority of whom had the acral type, to assess the safety and preliminary efficacy of OH2.Methods The trial enrolled patients with histologically confirmed unresectable stage III or advanced stage IV melanoma. …”
    Get full text
    Article
  12. 292

    Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden by R. Brüning, M. Tiede, M. Schneider, P. Wohlmuth, H. Weilert, K. Oldhafer, A. Stang

    Published 2020-01-01
    “…Percutaneous hepatic perfusion with melphalan (PHP-M) for hepatic metastasis of uveal melanoma (LMUM) achieves high local response rates, but the individual clinical benefit is poorly defined. …”
    Get full text
    Article
  13. 293

    A novel lectin from mushroom Phellodon melaleucus displays hemagglutination activity, and antitumor activity in a B16 melanoma mouse model by Yuanhui Li, Peng Wang, Zejun Zhang, Qinghong Liu

    Published 2023-09-01
    “…Circular dichroism (CD) spectroscopic analysis showed that PML was composed primarily of β-sheets with low α-helix content. In a B16 melanoma mouse model, PML treatment significantly inhibited tumor growth, and increased cytokine IL-10 content. …”
    Get full text
    Article
  14. 294

    Long-Term Followup Comparing Two Treatment Dosing Strategies of 125I Plaque Radiotherapy in the Management of Small/Medium Posterior Uveal Melanoma by Timothy G. Murray, Arnold M. Markoe, Aaron S. Gold, Fiona Ehlies, Ernesto Bermudez, Andrea Wildner, Azeema Latiff

    Published 2013-01-01
    “…To investigate the efficacy of two different dosing strategies of radioactive iodine-125 (125I) in the management of small- and medium-sized posterior uveal melanoma. Patients and Methods. The medical records of consecutive patients with choroidal melanomas between 1.5 and 5.0 mm in apical height treated initially with 125I plaque radiotherapy were reviewed. …”
    Get full text
    Article
  15. 295
  16. 296
  17. 297
  18. 298
  19. 299
  20. 300

    Skin Tumors Diagnosis Utilizing Case Based Reasoning and The Expert System by Roza Fuad Majeed, Soran AB. M. Saeed, Dana Abdulmajeed Abdilkarim, Haval Mohammed Sidqi

    Published 2020-06-01
    Subjects: “…Keywords: Skin cancer, BCC, SCC, melanoma, CBR, expert system.…”
    Get full text
    Article